These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23289944)

  • 1. Screening for substance abuse and diversion in Virginia hospices.
    Blackhall LJ; Alfson ED; Barclay JS
    J Palliat Med; 2013 Mar; 16(3):237-42. PubMed ID: 23289944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do Palliative Care Clinics Screen for Substance Abuse and Diversion? Results of a National Survey.
    Tan PD; Barclay JS; Blackhall LJ
    J Palliat Med; 2015 Sep; 18(9):752-7. PubMed ID: 26302425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and Assessment of Substance Use in Hospice Care: Examining Content from a National Sample of Psychosocial Assessments.
    Sacco P; Cagle JG; Moreland ML; Camlin EAS
    J Palliat Med; 2017 Aug; 20(8):850-856. PubMed ID: 28333571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A National Survey of Challenges Faced by Hospices During the Opioid Crisis: Estimates of Pain Medication Shortages, Missing Medications, and Opioids Left in the Home Post-Death.
    Cagle JG; McPherson ML; Frey JJ; Sacco P; Ware OD; Hoffmann D; Guralnik JM
    J Pain Symptom Manage; 2021 Oct; 62(4):738-746. PubMed ID: 33652093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled substances in hospices after patient death: a cross-sectional survey of Ontario hospices.
    Patel T; Hasan S; Chang F; McFarlane T
    Int J Clin Pharm; 2020 Oct; 42(5):1344-1353. PubMed ID: 32813214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for substance abuse risk in cancer patients using the Opioid Risk Tool and urine drug screen.
    Barclay JS; Owens JE; Blackhall LJ
    Support Care Cancer; 2014 Jul; 22(7):1883-8. PubMed ID: 24563103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
    Sehgal N; Manchikanti L; Smith HS
    Pain Physician; 2012 Jul; 15(3 Suppl):ES67-92. PubMed ID: 22786463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dying on Hospice in the Midst of an Opioid Crisis: What Should We Do Now?
    Gabbard J; Jordan A; Mitchell J; Corbett M; White P; Childers J
    Am J Hosp Palliat Care; 2019 Apr; 36(4):273-281. PubMed ID: 30352517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study.
    Ives TJ; Chelminski PR; Hammett-Stabler CA; Malone RM; Perhac JS; Potisek NM; Shilliday BB; DeWalt DA; Pignone MP
    BMC Health Serv Res; 2006 Apr; 6():46. PubMed ID: 16595013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmed Medication Diversion in Hospice Care: Qualitative Findings From a National Sample of Agencies.
    Ware OD; Cagle JG; McPherson ML; Sacco P; Frey J; Guralnik J
    J Pain Symptom Manage; 2021 Apr; 61(4):789-796. PubMed ID: 32931903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables.
    Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD
    Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bringing all the players to the table: the West Virginia Controlled Substance Advisory Board.
    Hannah KL; O'Neil M
    W V Med J; 2010; 106(4 Spec No):22-4. PubMed ID: 21932749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002.
    Gilson AM; Ryan KM; Joranson DE; Dahl JL
    J Pain Symptom Manage; 2004 Aug; 28(2):176-88. PubMed ID: 15276196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary resuscitation policies in northwest England hospices: a telephone survey.
    Douglas CA; Lewis-Jones C
    Int J Palliat Nurs; 2004 Dec; 10(12):588-91. PubMed ID: 15750519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France.
    Pauly V; Pradel V; Pourcel L; Nordmann S; Frauger E; Lapeyre-Mestre M; Micallef J; Thirion X
    Drug Alcohol Depend; 2012 Nov; 126(1-2):13-20. PubMed ID: 22475815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results from the national hospice volunteer training survey.
    Wittenberg-Lyles E; Schneider G; Oliver DP
    J Palliat Med; 2010 Mar; 13(3):261-5. PubMed ID: 20078210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain management in primary care: strategies to mitigate opioid misuse, abuse, and diversion.
    McCarberg BH
    Postgrad Med; 2011 Mar; 123(2):119-30. PubMed ID: 21474900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for drug diversion in a pain clinic patient population.
    Walker MJ; Webster LR
    J Opioid Manag; 2012; 8(6):351-62. PubMed ID: 23264313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.